Article
Prognostic Factors for Survival After Recurrence in Patients With Completely Resected Lung Adenocarcinoma: Important Roles of Epidermal Growth Factor Receptor Mutation Status and the Current Staging System.
Clinical lung cancer - 1 Nov 2015
Kudo Yujin, Shimada Yoshihisa, Saji Hisashi, Kato Yasufumi, Yoshida Koichi, Matsubayashi Jun, Nagase Seisuke, Kakihana Masatoshi, Kajiwara Naohiro, Ohira Tatsuo, Nagao Toshitaka, Ikeda Norihiko
Abstract excerpt
UNLABELLED: Epidermal growth factor receptor (EGFR) status and pathological stage (p-stage) were shown to be essential prognostic factors for estimating survival after recurrence of lung adenocarcinoma. In patients with EGFR mutations, those with early p-stage tumors showed better survival after disease recurrence than those with advanced p-stage tumors. The EGFR mutation status and p-stage could also prompt the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.